Results of a Prospective Phase 2 Study of Pazopanib in Patients With Surgically Unresectable or Metastatic Chondrosarcoma
Cancer - United States
doi 10.1002/cncr.32515
Full Text
Open PDFAbstract
Available in full text
Date
September 11, 2019
Authors
Publisher
Wiley